-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613.O3.6 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Risk Stratification and CAR-T Therapies

Symposia: Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Clinical trials, Research, Lymphoid Leukemias, ALL, Adult, Elderly, Clinical Practice (Health Services and Quality), Clinical Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Pediatric, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Real-world evidence, Lymphoid Malignancies, Registries, Study Population, Human, Measurable Residual Disease
Monday, December 9, 2024: 4:30 PM-6:00 PM
Marriott Grand Ballroom 5-6 (Marriott Marquis San Diego Marina)
Moderators:
Selina Luger, MD, FRCPC, University of Pennsylvania and Vinod Pullarkat, MD,
Disclosures:
Luger: Amgen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Novartis: Consultancy, Membership on an entity's Board of Directors or advisory committees; Daiichi Sankyo: Membership on an entity's Board of Directors or advisory committees; Marker Therapeutics: Membership on an entity's Board of Directors or advisory committees; Takeda: Research Funding; AbbVie: Membership on an entity's Board of Directors or advisory committees; Astellas: Consultancy. Pullarkat: Abbvie: Consultancy, Honoraria, Speakers Bureau; Novartis: Consultancy, Honoraria; Amgen: Speakers Bureau; Sobi: Speakers Bureau; Jazz: Speakers Bureau; Alexion: Honoraria; Rigel: Consultancy, Honoraria; sanofi: Consultancy.
4:30 PM

Nicola Goekbuget, MD1, Folker Schneller, MD2*, Kathrin Nachtkamp Sr., MD3*, Joachim Beck, MD4*, Christoph Faul, MD5, Ralph Wäsch6, Tobias Gaska, MD7, Lisa Heberling, MD8*, Knut Wendelin9*, Thomas Kubin, MD10*, Sonja Martin, MD11*, Lino L. Teichmann, MD12*, Veit L. Buecklein, MD13*, Walter Fiedler, MD14, Christian Junghanss, MD15*, Claudia D Baldus, MD16*, Monika Brüggemann, MD17*, Stefan Schwartz, MD18*, Axel Benner19*, Nicholas Schreck19*, Lena Reiser1*, Hubert Serve, MD1 and Andreas Viardot, MD, PhD20

1Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany
2Klinikum Rechts der Isar der TU München, Munich, Germany
3Dept. of Hematology, Oncology and Clinical Immunology, University of Düsseldorf, Düsseldorf, Germany
4Department of Medicine III, Universitätsmedizin Mainz, Mainz, Germany
5Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tübingen, Germany
6Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Albert Ludwigs University (ALU), Freiburg, Germany, Freiburg, Germany, Freiburg, Germany
7Brüderkrankenhaus St. Josef, Paderborn, Germany
8University Hospital Dresden, TU Dresden, Germany, Dresden, Germany
9Med Clinic 5, Klinikum Nürnberg, Nuernberg, Germany
10Klinikum Traunstein, Traunstein, Germany
11Robert-Bosch-Hospital, Stuttgart, Germany
12Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Bonn, Germany
13Department of Medicine III, LMU University Hospital, Munich, Germany
14Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
15Department of Internal Medicine II (Hematology/Oncology), University Medical Center, Rostock, DEU
16Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein, Kiel, Germany
17University Medical Center Schleswig-Holstein, University Cancer Center Schleswig-Holstein, Kiel, Germany
18Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany
19Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
20Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany

4:45 PM

Anna Torrent, MD1,2*, Mireia Morgades3*, Beatriz Soriano4*, Jordi Ribera3*, Susana Barrera5*, Pau Montesinos, PhD, MD6*, Eulàlia Genescà3*, José González-Campos, M.D.7*, Pere Barba, MD8,9, Jordi Esteve, MD, PhD10,11, Marta Sitges12*, Maria Paz Queipo De Llano13*, Carmen Botella14*, Clara Maluquer Artigal, MD15*, Irene García-Cadenas, MD16*, Marisa Calabuig17*, Alberto Hernández Sánchez, MD5*, Laura Torres, MD18*, Isabel Granada, MD3*, Jesus Maria Hernandez Rivas, MD19, Alberto Orfao, MD, PhD4* and Josep-Maria Ribera, MD, PhD20,21

1Hematology department, Institut Català D'oncologia-Hospital Germans Trias I Pujol. Josep Carrera, Badalona, Spain
2Institut Català D'oncologia-Hospital Germans Trias I Pujol. Josep Carrera, Badalona, ESP
3ICO-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain
4Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain
5Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC – University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain. IBSAL (Salamanca, Spain), Salamanca, Spain
6Hematology, Hospital Universitari I Politécnic La Fe and Programa Español de Tratamientos en Hematología (PETHEMA) Group, Valencia, Spain
7Hematology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain, Sevilla, Spain
8Deparment of Hematology, Vall Hebron Institute of Oncology (VHIO), Hospital Universitari Vall D'Hebron, La Garriga, Barcelona, Spain
9Vall d’Hebron Institute of Oncology (VHIO), Department of Hematology, University Hospital Vall d'Hebron, Universitat Autònoma of Barcelona (UAB), Barcelona, Spain
10Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
11Hematology Department, Hospital Clínic Barcelona, ICAMS, Barcelona, Spain
12Hematology Department, Institut Català d`Oncologia, Girona, ESP
13Hematology Department Hospital Universitario Virgen de la Victoria, Málaga, Spain, Malaga, ESP
14Hospital General Universitario de Alicante, Alicante, Spain
15Hematology Department. Institut Català d’Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
16Hematology Service, Hospital Santa Creu i Sant Pau, Barcelona, Spain
17Hematology Department, Hospital Clínico de Valencia. Instituto de Investigación Sanitaria INCLIVA de Valencia, Valencia, Spain., Valencia, Spain
18Hematology Department, Hospital Universitario la Fe de Valencia, Valencia, Spain., Valencia, Spain
19Department of Hematology - Hospital Universitario de Salamanca, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain
20Ico-Hospital Universitari Germans Trias Y Pujol, Badalona, Barcelona, ESP
21Josep Carreras Leukemia Research Institute, Badalona, Barcelona, Spain., Badalona, Spain

5:00 PM

Elias Jabbour, MD1, Jae H. Park, MD2, Paul Shaughnessy, MD3, Aaron C. Logan, MD, PhD4, Karamjeet S Sandhu, MD5, Mehrdad Abedi, MD6*, Bijal D Shah, MD7, Michael R Bishop, MD8, Daniel J. DeAngelo, MD, PhD9, Pierre Lao-Sirieix, PhD10*, Wolfram Brugger, MD11*, Martin A Pule, MD10*, Yiyun Zhang, PhD12* and Claire Roddie, MD13*

1University of Texas MD Anderson Cancer Center, Houston, TX
2Memorial Sloan Kettering Cancer Center, New York, NY
3Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX
4Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, University of California at San Francisco, San Francisco, CA
5City of Hope National Medical Center, Duarte, CA
6University of California Davis, Davis, CA
7Moffitt Cancer Center, Tampa, FL
8The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
9Dana-Farber Cancer Institute, Boston, MA
10Autolus Therapeutics, London, United Kingdom
11Autolus Therapeutics, Munich, Germany
12Autolus Therapeutics, Rockville, MD
13University College London Cancer Institute, London, United Kingdom

5:15 PM

Jing PAN, MD, PhD1, Liping Zhao2*, Fan Wu3*, Zhuojun Ling3* and Kai Wang3*

1Dept of Hemato-Oncology and immunotherapy, Beijing Gobroad Hospital, Beijing, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3Dept of Hemato-Oncology and immunotherapy, Beijing GoBroad Hospital, Beijing, China

5:30 PM

Susana Rives1,2*, Giorgio Ottaviano3*, Nuria Martínez-Cibrián, MD4*, Shatha Y. Farhan, MD5, Sowjanya Vuyyala, MBBS6,7, Jacques-Emmanuel Galimard, PhD8*, Eva Michel9*, Fizza Imran9*, Nazaret Sánchez-Sierra, MD10*, Richard Mitchell, MBBS11*, Stephan Mielke, MD12, Andishe Attarbaschi, MD13*, Soeren Lykke Petersen, MD, MSc14*, Samppa Ryhanen Sr., MD, PhD15, Wolfgang Andreas Bethge, MD16*, David Beauvais, MD17*, Tsila Zuckerman, MD18, Antonio Pérez-Martínez19,20,21,22*, Krzysztof Kalwak, MD, PhD23*, Fabio Ciceri, MD24*, Annalisa Ruggeri, MD, PhD25*, Julio Delgado, MD, PhD26,27*, Sebastian Giebel, MD, PhD28*, Adriana Balduzzi, MD29,30, Anna Alonso-Saladrigues, MD1,2,31* and Valentin Ortiz-Maldonado, MD, PhD, MSc26

1Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain
2Institut de Recerca Sant Joan de Déu, Barcelona, Spain
3Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
4Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Barcelona, Spain
5Department of Stem Cell Transplant and Cellular Therapy, Henry Ford Hospital, Detroit, MI
6Hematology and Oncology, Mayo Clinic, Rochester, MN
7Hematology and Oncology, Mayo Clinic, Rochester
8EBMT Paris Office, Hôpital Saint Antoine, Paris, France
9EBMT Paris Study Unit, Saint Antoine Hospital, INSERM UMR-S 938, Sorbonne University, Paris, France
10Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain
11Kids Cancer Centre, Sydney Children`s Hospital, Randwick, Australia
12Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska Comprehensive Cancer Center and ATMP Center, Karolinska Institutet and University Hospital, Stockholm, Sweden
13Department of Pediatric Hematology and Oncology, St. Anna Kinderspital, Vienna, Austria
14Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark
15Hospital For Children and Adolescent, Helsinki University Central Hospital, Helsinki, Finland
16Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tübingen, Germany
17Hematology Department., CHRU Lille, Lille, FRA
18Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Moshav Ein Ayalla, Israel
19Department of Pediatric Hemato-Oncology, University Hospital La Paz, Madrid, Spain
20CIBERER-ISCIII,, Madrid, Spain
21Pediatric Department, Autónoma University of Madrid, Madrid, Spain
22IdiPAZ-CNIO Pediatric Onco-Hematology Clinical Research Uni, Madrid, Spain
23Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University, Wroclaw, Poland
24Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. San Raffaele Scientific Institute, Milan, Italy
25Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
26Hospital Clínic de Barcelona, Barcelona, Spain
27Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona, Spain
28Department of Hematology and Bone Marrow Transplantation, Maria Sklodowska-Curie Institute of Oncology, Gliwice, Poland
29Fondazione IRCCS San Gerardo dei Tintori, Pediatric Hematopoietic Stem Cell Transplant Unit, Monza, Italy
30University of Milano-Bicocca, School of Medicine and Surgery, Monza, Italy
31University of Barcelona, Barcelona, Spain

5:45 PM

Ibrahim Aldoss, MD1, Xiuli Wang, PhD2, Jianying Zhang, PhD3*, Min Guan, MD, PhD4*, Ruby Espinosa4*, Vaibhav Agrawal, M.D.1, Andrew Artz, MD, MS5, Neguine Sanani, RN6*, Lior Goldberg, MD, MSc7*, Teresa Kim5*, Stephanie Kasten6*, Dileshni Tilakawardane, MS8*, Mary C Clark, PhD9*, Jamie R Wagner8*, Jinny Paul, PhD8*, Anthony S. Stein, MD1, Vinod Pullarkat, MD8, Amandeep Salhotra, MD10, Ahmed Aribi, MD11*, Guido Marcucci12 and Stephen J. Forman, MD, FACP8

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2Cellular Immunotherapy Center, Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute of City of Hope, Duarte, CA
3Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, City of Hope National Medical Center, Duarte, CA
4Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte
5City of Hope National Medical Center, Duarte, CA
6City of Hope, Duarte, CA
7Department of Pediatrics, City of Hope National Medical Center, Duarte, CA
8Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
9Department of Clinical and Translational Project Development, City of Hope, Duarte, CA
10Hematology and HCT, City of Hope National Medical Center, Duarte, CA
11Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
12Department of Hematologic Malignancies Translational Science, Duarte, CA

*signifies non-member of ASH